BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37767484)

  • 1. Myricetin as a promising inhibitor of platelet fibrinogen receptor in humans.
    Chang Y; Hsia CW; Huang WC; Jayakumar T; Hsia CH; Yen TL; Sheu JR; Hou SM
    Heliyon; 2023 Oct; 9(10):e20286. PubMed ID: 37767484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Garcinol acts as a novel integrin α
    Hsia CW; Huang WC; Jayakumar T; Hsia CH; Hou SM; Chang CC; Yen TL; Sheu JR
    Life Sci; 2023 Aug; 326():121791. PubMed ID: 37211346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin: regulation by integrin α
    Hou SM; Hsia CW; Tsai CL; Hsia CH; Jayakumar T; Velusamy M; Sheu JR
    J Biomed Sci; 2020 May; 27(1):60. PubMed ID: 32375785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antithrombotic Agent Pterostilbene Interferes with Integrin α
    Huang WC; Lin KC; Hsia CW; Hsia CH; Chen TY; Bhavan PS; Sheu JR; Hou SM
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ agonists negatively regulate αIIbβ3 integrin outside-in signaling and platelet function through up-regulation of protein kinase A activity.
    Unsworth AJ; Kriek N; Bye AP; Naran K; Sage T; Flora GD; Gibbins JM
    J Thromb Haemost; 2017 Feb; 15(2):356-369. PubMed ID: 27896950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.
    Hsia CH; Velusamy M; Sheu JR; Khamrang T; Jayakumar T; Lu WJ; Lin KH; Chang CC
    Sci Rep; 2017 Aug; 7(1):9556. PubMed ID: 28842683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α
    Hsia CH; Lu WJ; Lin KH; Chou DS; Geraldine P; Jayakuma T; Chang NC; Sheu JR
    J Cell Mol Med; 2018 Apr; 22(4):2142-2152. PubMed ID: 29369482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Human Platelet Activation via Integrin α
    Hsia CW; Tsai CL; Sheu JR; Lu WJ; Hsia CH; Velusamy M; Jayakumar T; Li JY
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling.
    Phillips DR; Nannizzi-Alaimo L; Prasad KS
    Thromb Haemost; 2001 Jul; 86(1):246-58. PubMed ID: 11487013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis.
    Qiao J; Wu X; Luo Q; Wei G; Xu M; Wu Y; Liu Y; Li X; Zi J; Ju W; Fu L; Chen C; Wu Q; Zhu S; Qi K; Li D; Li Z; Andrews RK; Zeng L; Gardiner EE; Xu K
    Haematologica; 2018 Sep; 103(9):1568-1576. PubMed ID: 29794149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide LSARLAF induces integrin β3 dependent outside-in signaling in platelets.
    Niu H; Xu Z; Li D; Zhang L; Wang K; Taylor DB; Liu J; Gartner TK
    Thromb Res; 2012 Aug; 130(2):203-9. PubMed ID: 22482832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet activity of chrysin via inhibiting platelet αIIbβ3-mediated signaling pathway.
    Liu G; Xie W; He AD; Da XW; Liang ML; Yao GQ; Xiang JZ; Gao CJ; Ming ZY
    Mol Nutr Food Res; 2016 Sep; 60(9):1984-93. PubMed ID: 27006308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
    Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W
    Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAR1 activation initiates integrin engagement and outside-in signalling in megakaryoblastic CHRF-288 cells.
    Cichowski K; Orsini MJ; Brass LF
    Biochim Biophys Acta; 1999 Jul; 1450(3):265-76. PubMed ID: 10395938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extract of Seaweed
    Kim TI; Kim YJ; Kim K
    Front Pharmacol; 2021; 12():685948. PubMed ID: 34276375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin αIIbβ3 outside-in signaling activates human platelets through serine 24 phosphorylation of Disabled-2.
    Tsai HJ; Cheng JC; Kao ML; Chiu HP; Chiang YH; Chen DP; Rau KM; Liao HR; Tseng CP
    Cell Biosci; 2021 Feb; 11(1):32. PubMed ID: 33557943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for the regulation of Syk from agglutination to aggregation in human platelets.
    Shih CH; Chiang TB; Wang WJ
    Biochem Biophys Res Commun; 2014 Jan; 443(2):580-5. PubMed ID: 24326074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proline-rich tyrosine kinase Pyk2 regulates platelet integrin αIIbβ3 outside-in signaling.
    Cipolla L; Consonni A; Guidetti G; Canobbio I; Okigaki M; Falasca M; Ciraolo E; Hirsch E; Balduini C; Torti M
    J Thromb Haemost; 2013 Feb; 11(2):345-56. PubMed ID: 23216754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct roles for Rap1b protein in platelet secretion and integrin αIIbβ3 outside-in signaling.
    Zhang G; Xiang B; Ye S; Chrzanowska-Wodnicka M; Morris AJ; Gartner TK; Whiteheart SW; White GC; Smyth SS; Li Z
    J Biol Chem; 2011 Nov; 286(45):39466-77. PubMed ID: 21940635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.